September 03, 2024 07:05 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful…
According to filings with the U.S. Securities and Exchange Commission, Circle Pharma is raising up to $117,374,782.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, David Earp…
South San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Circle Pharma is raising $66,304,990.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer,…
South San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Circle Pharma is raising $45,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Earp…